Aura Biosciences, Inc.

NasdaqGM:AURA Stock Report

Market Cap: US$341.8m

Aura Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGM:AURA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
23 Jan 24SellUS$50,521Julie FederIndividual6,609US$7.64
23 Jan 24SellUS$121,141Elisabet de los PinosIndividual15,853US$7.64
09 Nov 23BuyUS$14,040,000Matrix Capital Management Company, LPCompany1,560,000US$9.00
08 Nov 23BuyUS$1,434,987David JohnsonIndividual199,601US$7.30
30 Oct 23SellUS$65,478Elisabet de los PinosIndividual9,586US$6.83
30 Oct 23SellUS$23,091Julie FederIndividual3,385US$6.82
04 Oct 23BuyUS$168,175David JohnsonIndividual20,066US$8.61

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of AURA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,1540.00637%
Individual Insiders581,7071.17%
General Public2,891,6415.84%
VC/PE Firms3,039,8926.14%
Hedge Funds15,064,14230.4%
Institutions27,962,77356.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 31.1%.


Top Shareholders

Top 25 shareholders own 88.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14%
Matrix Capital Management Company, LP
6,922,870US$47.8m0%0.44%
11.7%
Eventide Asset Management, LLC
5,802,682US$40.0m0%0.77%
9.01%
Adage Capital Management, L.P.
4,465,000US$30.8m5.68%0.06%
7.42%
Citadel Advisors LLC
3,676,272US$25.4m1.24%0.03%
6.14%
Medicxi Ventures (UK) LLP
3,039,892US$21.0m0%5.68%
4.93%
BlackRock, Inc.
2,444,841US$16.9m16.5%no data
4.09%
Advent Life Sciences LLP
2,023,857US$14.0m0%100.0%
4.07%
Lundbeckfonden BioCapital
2,017,652US$13.9m0%0.25%
3.41%
The Vanguard Group, Inc.
1,687,410US$11.6m-2.49%no data
3.04%
Arix Bioscience plc
1,508,483US$10.4m0%100.0%
2.93%
Franklin Resources, Inc.
1,453,363US$10.0m142%no data
2.67%
Nantahala Capital Management, LLC
1,321,860US$9.1m0%1.07%
2.46%
Chiesi Ventures
1,218,803US$8.4m0%100.0%
2.01%
Goldman Sachs Group, Investment Banking and Securities Investments
996,643US$6.9m-3.92%no data
1.58%
Regency Capital Management Inc.
785,136US$5.4m11.4%3.76%
1.58%
Geode Capital Management, LLC
781,190US$5.4m15.5%no data
1.2%
T. Rowe Price Group, Inc.
595,540US$4.1m-9.72%no data
1.15%
State Street Global Advisors, Inc.
569,804US$3.9m12.6%no data
1.04%
Decheng Capital LLC
515,555US$3.6m0%1.29%
1%
Long Focus Capital Management LLC
495,422US$3.4m45.5%0.42%
0.72%
Ensign Peak Advisors, Inc.
357,222US$2.5m0%no data
0.6%
Northern Trust Global Investments
296,323US$2.0m19.3%no data
0.59%
FMR LLC
294,654US$2.0m-17.5%no data
0.58%
David Johnson
285,667US$2.0m-32.8%no data
0.45%
Jefferies Group LLC, Asset Management Arm
222,497US$1.5m0%0.1%
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.